Product Information
TRILEPTAL 600 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $19.3097 per EA under NDC 00078045705. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jan 14, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the oxcarbazepine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
600 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078045705
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXCARBAZEPINEApproval Type
New Drug (NDA)
FDA Application
NDA021014FDA Approved
1/14/2000
TE Code
AB
On Market Since
1/30/2000
Pharmacological Classes
Price Statistics
The NADAC for TRILEPTAL 600 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 146.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.3097 per EA |
|---|---|
| All-time high | $19.3145 (Aug 12, 2026) |
| All-time low | $7.7603 (Dec 18, 2013) |
| 52-week high | $19.3145 |
| 52-week low | $18.7071 |
| Median price | $15.4064 |
| Average price | $14.8614 |
| Largest weekly change | +14.9% (Jan 14, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRILEPTAL 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRILEPTAL 600 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $19.3097 per EA (NDC 00078045705), effective Aug 19, 2026.
How has the price of TRILEPTAL 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRILEPTAL 600 MG TABLET has risen 146.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRILEPTAL 600 MG TABLET?
Since Nov 28, 2013, the NADAC for TRILEPTAL 600 MG TABLET has ranged from a low of $7.7603 (Dec 18, 2013) to a high of $19.3145 (Aug 12, 2026), with a median of $15.4064 per EA.
Are there cheaper alternatives to TRILEPTAL 600 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXCARBAZEPINE 600 MG TABLET, is $0.3130 per EA — about 98% below TRILEPTAL 600 MG TABLET.
Who manufactures TRILEPTAL 600 MG TABLET?
TRILEPTAL 600 MG TABLET (NDC 00078045705) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.